Cafepharma Today

July 26 2024 - Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

EntreMed says CEO, CFO to leave, cuts 60 pct jobs
Reuters
Tuesday, December 16, 2008 - 7:22am
tags:
EntreMed, layoffs
FibroGen initiates trial of cancer drug
Bizjournals.com
Tuesday, December 16, 2008 - 7:20am
tags:
FibroGen, cancer
In A First, Pfizer Doesn't Raise Dividend
Forbes
Tuesday, December 16, 2008 - 7:08am
tags:
Pfizer
Solvay Welcomes FDA Approval For Cholesterol Drug
CNN Money
Tuesday, December 16, 2008 - 6:18am
tags:
Solvay, Abbott Laboratories, TriLipix
Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US
Yahoo
Tuesday, December 16, 2008 - 6:15am
tags:
Cell Therapeutics, Spectrum Pharmaceuticals, Zevalin
Biotech Stocks with Good Genes
Barrons
Tuesday, December 16, 2008 - 6:14am
tags:
Amgen, Osiris Therapeutics, Cubist Pharmaceuticals
Hana Bio Shares Stay Submerged
Yahoo/Zacks.com
Monday, December 15, 2008 - 10:22pm
tags:
Hana Biosciences
FDA Approves Genzymes Mozobil
Yahoo
Monday, December 15, 2008 - 10:22pm
tags:
Genzyme, Mozobil, non-Hodgkin's lymphoma
Abbott says FDA approves cholesterol drug TriLipix
Yahoo/AP
Monday, December 15, 2008 - 9:06pm
tags:
TriLipix, Abbott Laboratories
FDA Verdict Could Determine Future Of Personalized Medicine
Forbes
Monday, December 15, 2008 - 4:12pm
tags:
FDA, cancer, genetic testing
Elan Under Fire: Tysabri Infection; Investors Slam CEO Performance
WSJ Online
Monday, December 15, 2008 - 3:01pm
tags:
Elan, Tysabri, Biogen Idec, MS
Adventrx Exploring Strategic Options
PharmaLive
Monday, December 15, 2008 - 2:58pm
tags:
Adventrx
Durect to Rebound from Setback
Yahoo/Zacks.com
Monday, December 15, 2008 - 2:54pm
tags:
Durect Corporation, Alpharma
Exelixis shares return prior week's gains from Bristol-Myers partnership as market falls
Yahoo/AP
Monday, December 15, 2008 - 2:52pm
tags:
Bristol-Myers Squibb, Exelixis
AstraZeneca Ties To Nobel Foundation Questioned
Pharmalot
Monday, December 15, 2008 - 12:21pm
tags:
AstraZeneca
Cornerstone Gets $6 Million Investment to Fund Cancer Drug Trials
NJBIZ
Monday, December 15, 2008 - 12:09pm
tags:
cancer, Cornerstone Therapeutics, drug trials
UCSF says reports on drug trials skew positive
San Fransisco Chronicle, CA
Monday, December 15, 2008 - 12:06pm
tags:
drug trials, FDA
Deals of the Year Nominee: Novartis/Alcon
InVivo
Monday, December 15, 2008 - 11:03am
tags:
Novartis, Alcon
Elan, Biogen report new Tysabri brain disease case
Yahoo/AP
Monday, December 15, 2008 - 10:46am
tags:
Elan, Tysabri, MS, Biogen Idec
GlaxoSmithKline extends tender offer for Genelabs Technologies to meet 90 percent requirement
Yahoo/AP
Monday, December 15, 2008 - 10:17am
tags:
GSK, Genelabs

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Crafting Effective, Patient-Centric Channel Strategies
Drug Channels
Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers
Drug Channels
Optimizing Product Commercialization in Today’s IDN Environment
Drug Channels
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating
Drug Channels
At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs
Drug Channels
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts
Drug Channels
Breaking Down Medication Access and Affordability Barriers
Drug Channels
Drug Channels News Roundup, June 2024: Cordavis Humira Update, OptumRx’s New Biosim Biz, Generic Drugs' Wild Ride, IRA Predictions, and Dr. G on Med School
Drug Channels
Meet the Four Executives Headlining the Drug Channels Leadership Forum
Drug Channels

Latest Jobs

Account Executive - Hospice
Freeman, Missouri, 64746
Agape Care Group
Account Executive - Hospice
Wellington, Missouri, 64097
Agape Care Group
Account Executive - Hospice
Napoleon, Missouri, 64074
Agape Care Group
Healthcare Sales Professional
Denton, Texas, Texas
Tris Pharma
Psychiatry Account Manager - Santa Monica, CA
Santa Monica, California
Lundbeck
Senior Account Consultant, Durysta - San Diego, CA
San Diego, California, California
AbbVie
Senior Account Consultant, Retina - Hartford, CT
New Haven, Connecticut, Connecticut
AbbVie
Oncology Specialist - New York City
New York City, New York
AbbVie
Associate Director, Strategic Account Manager, Southern California
Los Angeles, California, California
AbbVie
Oncology Specialist - LA West
Santa Monica, California
AbbVie
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information